Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil effectively treats Female Pattern Hair Loss in women of all ages and hormone levels, but evidence for antiandrogens is limited.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

Hyperandrogenism, often causing excessive hair growth and acne, can be treated with methods like weight reduction, hair removal, various medications, and in the case of acne, topical treatments.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Combining Minoxidil with topical Dutasteride via microneedling is the most effective and safe treatment for hair loss.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

A 62-year-old woman with hair loss and scalp itching was diagnosed with lichen planopilaris, treated initially with topical corticosteroids, and other possible treatments include systemic steroids, antimalarials, and more.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Two treatments for male pattern hair loss are minoxidil and finasteride, but they have side effects and may not satisfy everyone.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Topical minoxidil helps hair regrowth in over 50% of men and women.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Minoxidil, tretinoin, and finasteride may help hair regrowth in mild to moderate androgenetic alopecia.

Clascoterone may be an effective topical treatment for hair loss.

Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.

Different hair loss treatments like topical mixtures, plasma infiltrations, and oral medicine can stop hair loss and improve hair density and follicle size.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

Citrullus colocynthis fruit extract may effectively treat testosterone-related hair loss, similar to finasteride.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

White wax and its policosanol boost hair growth better than finasteride.

Using a mix of finasteride and minoxidil can significantly regrow hair in men with pattern baldness.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.